Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2
- Authors: Polyakov Y.Y.1,2, Baryakh E.A.1,2,3, Misyurina E.N.1,2, Zhelnova E.I.1,2, Mingalimov M.A.1,2, Kardovskaya S.A.1, Smolyarchuk M.Y.4, Tolstykh T.N.1,2, Chudnova T.S.1,2, Ivanova D.D.1, Kochneva O.L.1, Lebedev D.V.1,5, Abueva A.U.1,6, Chistov A.M.7, Zotina E.N.1,2, Samsonova I.V.1,7, Lysenko M.A.1,7
-
Affiliations:
- City Clinical Hospital No. 52, Moscow Healthcare Department
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
- Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
- Medicine and Nuclear Technologies LLC
- Medical and Biological University of Innovation and Continuing Education, State Scientific Center of the Russian Federation – A.I. Burnazyan Federal Medical Biophysical Center, Federal Medical and Biological Agency
- Peoples’ Friendship University of Russia named after Patrice Lumumba
- N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- Issue: Vol 19, No 2 (2024)
- Pages: 101-108
- Section: CURRENT ASPECTS OF COVID-19 TREATMENT APPROACHES WITH SARS-COV-2 VIRUS PERSISTENCE IN ONCOLOGICAL/HEMATOLOGICAL PATIENTS
- Published: 02.04.2024
- URL: https://oncohematology.abvpress.ru/ongm/article/view/917
- DOI: https://doi.org/10.17650/1818-8346-2024-19-2-101-108
- ID: 917
Cite item
Full Text
Abstract
Treatment of immunocompromised patients with novel coronavirus infection (COVID-19) presents significant challenges. Currently, there are no unified approaches to the treatment of persistent COVID-19 in hematological malignancies. There is a need to develop recommendations for the management of such patients, chemotherapy protocols, as well as therapy for COVID-19 in case of SARS-CoV-2 virus persistence. Doctors are faced with cases of virus persistence, clinical manifestations during a long course of the infectious process and are not provided with methodological recommendations for patient supervision. As scientific data on the persistent COVID-19 course in patients with lymphoproliferative diseases accumulates, it is planned to create recommendations for the treatment of COVID-19 for patients in this group. This article describes a clinical case of persistent COVID-19 course in a comorbid patient with primary central nervous system large B-cell lymphoma during chemotherapy.
About the authors
Yu. Yu. Polyakov
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
Author for correspondence.
Email: yurij.polyakov86@yandex.ru
ORCID iD: 0009-0007-8389-6269
Yuriy Yu. Polyakov.
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationE. A. Baryakh
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
ORCID iD: 0000-0001-6880-9269
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991; Build. 1, 2/1 Barrikadnaya St., Moscow 125993
Russian FederationE. N. Misyurina
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0003-2419-4850
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationE. I. Zhelnova
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0002-0343-9348
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationM. A. Mingalimov
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0002-8491-2140
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationS. A. Kardovskaya
City Clinical Hospital No. 52, Moscow Healthcare Department
ORCID iD: 0000-0002-4220-7582
3 Pekhotnaya St., Moscow 123182
Russian FederationM. Ya. Smolyarchuk
Medicine and Nuclear Technologies LLC
ORCID iD: 0000-0001-9819-8657
Build. 322, 1 Akademika Kurchatova Ploshchad’, Moscow 123098
Russian FederationT. N. Tolstykh
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0001-7308-0927
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationT. S. Chudnova
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0002-8012-1640
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationD. D. Ivanova
City Clinical Hospital No. 52, Moscow Healthcare Department
ORCID iD: 0009-0004-3632-9198
3 Pekhotnaya St., Moscow 123182
Russian FederationO. L. Kochneva
City Clinical Hospital No. 52, Moscow Healthcare Department
ORCID iD: 0000-0003-1338-8203
3 Pekhotnaya St., Moscow 123182
Russian FederationD. V. Lebedev
City Clinical Hospital No. 52, Moscow Healthcare Department; Medical and Biological University of Innovation and Continuing Education, State Scientific Center of the Russian Federation – A.I. Burnazyan Federal Medical Biophysical Center, Federal Medical and Biological Agency
ORCID iD: 0009-0001-8480-5505
3 Pekhotnaya St., Moscow 123182; 46 Zhivopisnaya St., Moscow 123098
Russian FederationA. U. Abueva
City Clinical Hospital No. 52, Moscow Healthcare Department; Peoples’ Friendship University of Russia named after Patrice Lumumba
ORCID iD: 0009-0004-6952-4475
3 Pekhotnaya St., Moscow 123182; 6 Miklukho-Maklaya St., Moscow 117198
Russian FederationA. M. Chistov
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
ORCID iD: 0009-0000-1477-9981
1 Ostrovityanova St., Moscow 117997
Russian FederationE. N. Zotina
City Clinical Hospital No. 52, Moscow Healthcare Department; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
ORCID iD: 0000-0001-9692-2541
3 Pekhotnaya St., Moscow 123182; Build. 2, 8 Trubetskaya St., Moscow 119991
Russian FederationI. V. Samsonova
City Clinical Hospital No. 52, Moscow Healthcare Department; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
ORCID iD: 0000-0002-1228-1765
3 Pekhotnaya St., Moscow 123182; 1 Ostrovityanova St., Moscow 117997
Russian FederationM. A. Lysenko
City Clinical Hospital No. 52, Moscow Healthcare Department; N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
ORCID iD: 0000-0001-6010-7975
3 Pekhotnaya St., Moscow 123182; 1 Ostrovityanova St., Moscow 117997
Russian FederationReferences
Supplementary files

